Background: Paraoxonase1 (PON1), an enzyme connected to high density lipoproteins (HDL) particles, plays an important role in protecting arteries against atherosclerosis. The serum activity and concentration of PON1 depends on several genetic polymorphisms as well as environmental factors. Materials and methods: Investigated population consisted of 71 patients aged 43–76 years with confirmed coronary heart disease (CHD). Established risk factors of CHD such as hypertension, elevated total cholesterol and LDL cholesterol (LDL-C), low HDL cholesterol (HDL-C), diabetes mellitus, obesity, smoking and premature CHD in family history were assessed. PON1 genotype for −108C/T promotor region was determined by polymerase chain reaction-r...
ObjectivesThe goal of this study was to examine the association between paraoxonase-1 (PON1) activit...
PubMed ID: 20098041Objectives: Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated est...
Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) a...
Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein (HDL). PON1-...
Background: Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein ...
Aim: Paraoxonase-1 (PON1) is an antioxidant enzyme located in high density lipoprotein (HDL). PON1 w...
Background: Paraoxonase-1 (PON1) is a high-density lipoprotein (HDL)-associated serum enzyme that pr...
Abstract Background Coronary artery disease (CAD) is a leading cause of morbidity and mortality, wit...
The oxidation of low-density lipoproteins and cell membrane lipids is believed to play an integral r...
Background: Cardiovascular disease (CVD) is the most common cause of mortality and morbidity worldwi...
Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) a...
Aim and background: Coronary heart disease (CHD) is the major cause of mortality and morbidity world...
Objective: Serum Paraoxonase (PON) is a calcium dependent esterase which hydrolyses organophosphates...
AbstractThe anti-atherogenic effect of HDL has been suggested to be partly due to the action of HDL-...
Background: Paraoxonase-1(PON1), a high-density lipoprotein (HDL) associated enzyme, is believed to ...
ObjectivesThe goal of this study was to examine the association between paraoxonase-1 (PON1) activit...
PubMed ID: 20098041Objectives: Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated est...
Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) a...
Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein (HDL). PON1-...
Background: Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein ...
Aim: Paraoxonase-1 (PON1) is an antioxidant enzyme located in high density lipoprotein (HDL). PON1 w...
Background: Paraoxonase-1 (PON1) is a high-density lipoprotein (HDL)-associated serum enzyme that pr...
Abstract Background Coronary artery disease (CAD) is a leading cause of morbidity and mortality, wit...
The oxidation of low-density lipoproteins and cell membrane lipids is believed to play an integral r...
Background: Cardiovascular disease (CVD) is the most common cause of mortality and morbidity worldwi...
Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) a...
Aim and background: Coronary heart disease (CHD) is the major cause of mortality and morbidity world...
Objective: Serum Paraoxonase (PON) is a calcium dependent esterase which hydrolyses organophosphates...
AbstractThe anti-atherogenic effect of HDL has been suggested to be partly due to the action of HDL-...
Background: Paraoxonase-1(PON1), a high-density lipoprotein (HDL) associated enzyme, is believed to ...
ObjectivesThe goal of this study was to examine the association between paraoxonase-1 (PON1) activit...
PubMed ID: 20098041Objectives: Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated est...
Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) a...